Interaction Between Mivacurium and Succinylcholine

We investigated the interaction between mivacurium and succinylcholine when mivacurium was administered during the early recovery from succinylcholine block.We studied 40 adult patients during propofolalfentanil-N2 O-O2 anesthesia. Neuromuscular function was monitored using an electromyographic method (Relaxograph Registered Trademark; Datex, Helsinki, Finland). Patients randomly received either 1.0 mg/kg of succinylcholine followed by 0.15 mg/kg of mivacurium when the first twitch (T1) during succinylcholine block recovered to 5%, or 0.15 mg/kg of mivacurium without succinylcholine. Serum cholinesterase activity was lower than normal range in two patients and higher than normal range in four patients, but the dibucaine number value was normal in every patient. The mean onset time (3.8 +/- 0.9 min) (mean +/- SD) or maximal neuromuscular block (96.6% +/- 7.2%) of mivacurium did not differ between the groups. The T1 recovery times of mivacurium were slightly shorter (P < 0.05) after succinylcholine administration than without it. During recovery of mivacurium block, the fade was significantly greater, i.e., the train-of-four (TOF) ratio was lower, after succinylcholine administration than without it. Recovery index (T1 25%-75%, mean 4.7 +/- 1.3 min) and the time from the administration of mivacurium to the recovery of TOF ratio 0.7 (mean 20.4 +/- 5.1 min) were not different between the groups. In conclusion, in healthy patients succinylcholine has negligible effects on a subsequent mivacurium-induced neuromuscular block. (Anesth Analg 1995;80:534-7)

[1]  R. Dirksen,et al.  The Predictive Performance of a System Model for Enflurane Closed‐circuit Inhalational Anesthesia , 1993, Anesthesiology.

[2]  R. Welch,et al.  Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure. , 1992, British journal of anaesthesia.

[3]  R. M. Jones,et al.  Mivacurium chloride: a study to evaluate its use during propofol–nitrous oxide anaesthesia , 1992, Anaesthesia.

[4]  J. Hunter,et al.  Use of mivacurium chloride by constant infusion in the anephric patient. , 1992, British journal of anaesthesia.

[5]  K. Pearson,et al.  Neuromuscular and cardiovascular effects of mivacurium chloride (BW B1090U) during nitrous oxide-fentanyl-thiopentone and nitrous oxide-halothane anaesthesia. , 1990, British journal of anaesthesia.

[6]  C. Shanks,et al.  Mivacurium-induced neuromuscular blockade following single bolus doses and with continuous infusion during either balanced or enflurane anesthesia. , 1989, Anesthesiology.

[7]  R. Welch,et al.  In Vitro Metabolism of Mivacurium Chloride (BW B1090U) and Succinylcholine , 1989, Anesthesia and analgesia.

[8]  H. H. Ali,et al.  The Clinical Neuromuscular Pharmacology of Mivacurium Chloride (BW B1090U). A Short‐acting Nondepolarizing Ester Neuromuscular Blocking Drug , 1988, Anesthesiology.

[9]  M. Knedel,et al.  [A kinetic method for determination of the activity of pseudocholinesterase (acylcholine acyl-hydrolase 3.1.1.8.)]. , 1967, Klinische Wochenschrift.